These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 3038500)

  • 41. 6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.
    Moore BA; Brammer KW
    Antimicrob Agents Chemother; 1981 Sep; 20(3):327-31. PubMed ID: 6272628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
    Ball AP; Fox C; Ghosh D
    J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
    Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experiences with sultamicillin granules in pediatric patients].
    Iguchi K; Kamiya H; Sakurai M; Shimizu S; Nishi H; Kawaguchi H; Yoshizumi T; Inoue M; Kojima M
    Jpn J Antibiot; 1988 Dec; 41(12):1906-13. PubMed ID: 3249363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of sultamicillin in mice, rats, and dogs.
    English AR; Girard D; Haskell SL
    Antimicrob Agents Chemother; 1984 May; 25(5):599-602. PubMed ID: 6329091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE
    J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    Washburn RG; Durack DT
    J Infect Dis; 1981 Sep; 144(3):237-43. PubMed ID: 6268715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections.
    Reinhardt JF; Johnston L; Ruane P; Johnson CC; Ingram-drake L; MacDonald K; Ward KW; Mathisen G; George WL; Finegold SM
    Rev Infect Dis; 1986; 8 Suppl 5():S569-75. PubMed ID: 3026005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of beta-lactamases.
    Wittmann DH; Koltowski P; Oleszkiewicz J; Walker AP
    Infection; 1990; 18(1):41-7. PubMed ID: 2179137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
    Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
    Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A study on pharmacokinetics, antimicrobial activity and clinical efficacy of sultamicillin in children].
    Okazaki H; Kitamura N; Hirabayashi Y; Higashino H; Kobayashi Y
    Jpn J Antibiot; 1988 Dec; 41(12):1940-6. PubMed ID: 3249366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
    Brown RM; Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Apr; 21(4):565-7. PubMed ID: 6282211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
    Güneren MF
    Drugs; 1988; 35 Suppl 7():57-68. PubMed ID: 3065055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties.
    Greenwood D; Eley A
    J Antimicrob Chemother; 1982 Aug; 10(2):117-23. PubMed ID: 6288651
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease.
    Gunning J
    Drugs; 1986; 31 Suppl 2():14-7. PubMed ID: 3013567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacokinetic, bacteriological and clinical studies of sultamicillin fine granule in pediatric field].
    Ishikawa H; Takeuchi H; Kimura H; Hayakawa F; Yamamoto N; Nakao Y; Kuno K
    Jpn J Antibiot; 1988 Dec; 41(12):1895-905. PubMed ID: 3249362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
    Crombleholme WR; Ohm-Smith M; Robbie MO; DeKay V; Sweet RL
    Am J Obstet Gynecol; 1987 Feb; 156(2):507-12. PubMed ID: 3030109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.